New study finds procedures treating spinal fractures associated with reduction in opioid use and decreased payer costs

Dublin, dec. 13, 2021 /prnewswire/ -- medtronic plc (nyse: mdt), a global leader in healthcare technology, today announced the results of a study published in osteoporosis international that demonstrate a decrease, and in some cases elimination of oral opioids, and decrease in payer costs following balloon kyphoplasty (bkp) or vertebroplasty (vp) procedures in patients suffering from spinal fractures, known as vertebral compression fractures (vcf).1 this study, sponsored by medtronic, is the first published study to evaluate the effect of bkp and vp on opioid reduction as a primary outcome. an estimated 800,000 vcfs occur in the united states every year.2 they are associated with debilitating pain, spinal deformity, increased mortality, and increased healthcare-resource utilization in elderly patients.3-5 vcfs are often treated with conservative medical management (cmm), including bed rest, back bracing, and prescription oral opioids.
MDT Ratings Summary
MDT Quant Ranking